{"gene":"NEUROG3","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2000,"finding":"HNF-6 (ONECUT1) directly binds to and activates the ngn3 gene promoter, establishing HNF-6 as the first identified positive transcriptional regulator of Neurog3 in the developing pancreas. Loss of HNF-6 in mice nearly abolishes Ngn3 expression and impairs endocrine cell differentiation.","method":"Promoter binding assay, mouse knockout (hnf6-/-), expression analysis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct promoter binding demonstrated, corroborated by in vivo knockout phenotype showing loss of Ngn3 expression; replicated conceptually by later studies on upstream regulators","pmids":["10825208"],"is_preprint":false},{"year":2006,"finding":"Ngn3 directly binds chromatin at the IA1 promoter and activates IA1 transcription in adult pancreatic duct cells. IA1 expression is absent in Ngn3-null embryos but is normal in embryos mutant for downstream factors (NeuroD1, Arx, Pax4, Pax6), placing IA1 as a direct, early Ngn3 target gene.","method":"Chromatin immunoprecipitation (ChIP), ectopic Ngn3 expression in adult duct cells, genetic epistasis in multiple transcription factor mutant embryos","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP demonstrated direct chromatin binding; genetic epistasis in multiple mutant backgrounds firmly positions IA1 as direct Ngn3 target","pmids":["16511571"],"is_preprint":false},{"year":2008,"finding":"Ngn3 protein exhibits biphasic expression during mouse pancreatic development (E8.5–E11.0 first wave; E12.0 onward second wave), and Ngn3 transcripts are markedly more widespread than NGN3 protein in the pancreatic epithelium, indicating substantial post-transcriptional regulation of Ngn3.","method":"mRNA in situ hybridization, immunofluorescence protein detection throughout embryonic development","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct protein vs. mRNA comparison by two independent detection methods in one study; single lab","pmids":["18924236"],"is_preprint":false},{"year":2008,"finding":"Myt1b and Ngn3 form a feed-forward expression loop: Myt1b potentiates Ngn3 transcription in pancreatic progenitors, and Ngn3 protein production in turn induces Myt1 expression. Pancreatic Myt1 expression largely depends on Ngn3 activity.","method":"Gain-of-function overexpression, analysis of Ngn3-null mutant pancreata, expression profiling","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional epistasis using Ngn3-null mice plus gain-of-function; single lab, two complementary approaches","pmids":["18394599"],"is_preprint":false},{"year":2009,"finding":"Neurog3 mRNA and protein are present not only in endocrine progenitors but also in hormone-expressing islet cells (embryonic and adult). Conditional inactivation of Neurog3 in insulin-expressing beta cells or Pdx1-expressing islet cells impairs endocrine function and reduces expression of Neurog3 target genes required for islet maturation, demonstrating that sustained Neurog3 expression is required for islet maturation and function beyond its progenitor role.","method":"Neurog3 knock-in reporter mice (3 independent lines), mRNA/protein assays, conditional knockout (Cre-lox)","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — three independent reporter lines plus conditional KO with defined functional phenotype; multiple orthogonal methods in one study","pmids":["19487660"],"is_preprint":false},{"year":2009,"finding":"Neurog3 gene dosage directly controls endocrine commitment: high levels of Neurog3 are required for endocrine fate specification from multipotent pancreatic progenitors, while reduced Neurog3 expression causes progenitors to adopt ductal or acinar fates instead.","method":"Neurog3 heterozygosity and hypomorphic allele (gene-dosage manipulation), lineage analysis, cell fate tracking","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic gene dosage series (null, hypomorph, heterozygous, wild-type) with quantitative cell-fate readout; multiple alleles constitute independent replication within one study","pmids":["20025861"],"is_preprint":false},{"year":2010,"finding":"Rfx6 is transcriptionally downstream of Ngn3: Rfx6 expression is lost in Ngn3-null mice and is maintained in embryos lacking NeuroD, Pax4, and Arx, placing Rfx6 directly below Ngn3 in the endocrine differentiation hierarchy. Loss-of-function studies in zebrafish show Rfx6 is required for differentiation of glucagon-, ghrelin-, and somatostatin-expressing cells.","method":"Gene expression profiling of isolated Ngn3+ progenitors, analysis in Ngn3-null and other transcription factor mutant embryos (epistasis), zebrafish loss-of-function","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — epistasis in multiple mutant backgrounds definitively places Rfx6 downstream of Ngn3; zebrafish loss-of-function provides functional validation","pmids":["20040487"],"is_preprint":false},{"year":2011,"finding":"NEUROG3 is required for endocrine pancreas and enteroendocrine cell development in humans: biallelic loss-of-function mutations (including a nonsense mutation E28X and a missense L135P) abolish NEUROG3 binding to the NEUROD1 promoter E-box in vitro and eliminate its ability to induce ectopic endocrine cell formation and delamination in chicken endoderm electroporation assays. Patients with null mutations lack enteroendocrine cells entirely and develop neonatal diabetes.","method":"In vitro E-box binding assay (NEUROD1 promoter), in ovo chicken endoderm electroporation, intestinal biopsy immunostaining","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vitro biochemical assay plus in vivo functional assay; both mutant isoforms tested; human patient phenotype corroborates","pmids":["21378176"],"is_preprint":false},{"year":2011,"finding":"Ngn3-expressing endocrine progenitor cells provide a cell-extrinsic feedback signal to adjacent multipotent ductal progenitor cells that activates Notch signaling, limiting further endocrine differentiation and promoting proper duct morphogenesis. Ngn3-/- mice have reduced branching and enlarged duct-like structures, and forced surplus endocrine progenitors reduce duct caliber.","method":"Ngn3 knockout mouse analysis, forced endocrine progenitor generation, Notch signaling measurement","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function and gain-of-function with defined morphogenetic readout; single lab","pmids":["21888903"],"is_preprint":false},{"year":2011,"finding":"ATOH1/MATH1 is essential for intestinal tuft cell differentiation whereas Neurog3 is dispensable for tuft cell fate, distinguishing tuft cells from enteroendocrine cells (which require Neurog3).","method":"Conditional knockout mouse models (Neurog3-null, ATOH1-null), immunostaining for tuft cell markers","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function distinguishes Neurog3-dependent versus independent lineages; clean negative result for tuft cells is mechanistically informative","pmids":["21383077"],"is_preprint":false},{"year":2011,"finding":"Mutagenesis and chromatin immunoprecipitation demonstrate that Ngn3 directly targets the proximal E-boxes of the Insm2 promoter. Endogenous Insm2 expression is activated in Ngn3/NeuroD1-transduced pancreatic epithelial duct cells, establishing Insm2 as a direct transcriptional target of Ngn3.","method":"Promoter mutagenesis, chromatin immunoprecipitation (ChIP), ectopic Ngn3/NeuroD1 expression in pancreatic duct cells","journal":"Endocrinology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — ChIP and promoter mutagenesis directly demonstrate binding and transactivation; single lab but two complementary methods","pmids":["21343251"],"is_preprint":false},{"year":2012,"finding":"CCAR1 physically interacts with Ngn3 (verified by pull-down and co-immunoprecipitation) and is required as a coactivator for Ngn3 to activate NeuroD promoter-driven reporter gene expression. Knockdown of endogenous CCAR1 in PANC-1 cells inhibits Ngn3-initiated transdifferentiation toward endocrine fate.","method":"Pulldown assay, co-immunoprecipitation, luciferase reporter assay, siRNA knockdown","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal protein interaction assays plus functional reporter and knockdown; single lab","pmids":["22266316"],"is_preprint":false},{"year":2012,"finding":"STAT3 directly binds the distal Neurog3 promoter/enhancer region in THY1+ spermatogonia and regulates Neurog3 transcription. GDNF (a self-renewal factor for spermatogonial stem cells) suppresses STAT3 activation and consequently represses Neurog3 expression. Transient inhibition of Neurog3 in spermatogonia impairs SSC differentiation in vitro and in vivo transplantation assays.","method":"ChIP (STAT3 at Neurog3 promoter), pharmacological JAK/STAT inhibition, RNAi knockdown, transplantation assay","journal":"Biology of reproduction","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP demonstrates direct binding; multiple orthogonal methods (ChIP, RNAi, transplantation) in one study","pmids":["22378757"],"is_preprint":false},{"year":2013,"finding":"Notch signaling regulates Ngn3 not only at the transcriptional level but also via a post-translational mechanism: Notch>Hes1 pathway activation destabilizes Ngn3 protein. Inhibition of Notch signaling in mouse pancreas explants leads to Ngn3 protein stabilization. Ngn3 also cell-extrinsically activates the Dll1>Notch>Hes1 lateral inhibition pathway, which feeds back to limit endocrine differentiation.","method":"Conditional Ngn3 expression in pancreas, Notch inhibitor treatment of pancreas explants, protein stability assays","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological Notch inhibition with protein stabilization readout; conditional expression model; single lab","pmids":["23370147"],"is_preprint":false},{"year":2014,"finding":"Insm1 positively regulates Neurog3: embryos lacking Insm1 contain greater amounts of a non-coding Neurog3 mRNA splice variant and have fewer Neurog3/Insm1 co-expressing progenitor cells, suggesting Insm1 modulates correct Neurog3 mRNA splicing/expression during endocrine progenitor differentiation.","method":"Insm1 GFP-Cre reporter knock-in mouse, transcriptomic analysis of Insm1-null endocrine progenitors, expression profiling","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo genetic loss-of-function with transcriptomic readout; single lab","pmids":["25053427"],"is_preprint":false},{"year":2015,"finding":"NEUROG3 is required for human endocrine pancreas development: CRISPR/Cas9 biallelic disruption of NEUROG3 in human ESCs blocks endocrine cell formation both in vitro and after engraftment in mice. A 75–90% knockdown of NEUROG3 reduces but does not eliminate endocrine cell formation, and as little as 10% NEUROG3 is sufficient for endocrine cell production.","method":"CRISPR/Cas9 gene targeting in hESCs, in vitro differentiation, mouse engraftment, NEUROG3 knockdown titration","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — complete genetic knockout plus dose-response knockdown in human cell model, with both in vitro and in vivo readouts","pmids":["25650326"],"is_preprint":false},{"year":2015,"finding":"Hnf1b occupies Ngn3 putative regulatory sequences in vivo, and inactivation of Hnf1b at different embryonic time points results in absence of Ngn3+ endocrine precursors throughout embryogenesis, establishing Hnf1b as a direct upstream regulator required for endocrine progenitor generation.","method":"Constitutive and inducible conditional Hnf1b knockout mice, ChIP for Hnf1b at Ngn3 regulatory sequences, endocrine precursor quantification","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP demonstrates direct Hnf1b occupancy at Ngn3 locus; multiple conditional knockout models with consistent phenotype","pmids":["25715395"],"is_preprint":false},{"year":2016,"finding":"Inflammatory cytokines activate NGN3 expression in pancreatic ductal cells via STAT3 signaling, driving ductal-to-endocrine cell reprogramming both in vitro (human ductal cell line and mouse ductal cells) and in vivo (intraductal injection, NOD mouse autoimmune diabetes model).","method":"Cytokine treatment of human ductal cell line, pancreatic intraductal injection in mice, NOD mouse model, STAT3 inhibition","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo models with pathway inhibition; single lab, multiple models","pmids":["27068459"],"is_preprint":false},{"year":2016,"finding":"A mitotic Neurog3-transcriptionally-active but low-protein (Neurog3TA.LO) cell population in Sox9+ epithelium represents an endocrine-biased progenitor state with prolonged epithelial residency and high mitotic index, functionally separated from the endocrine-committed Neurog3HI state. Limiting Neurog3 expression doubles the mitotic index of this progenitor pool.","method":"BAC transgenic Neurog3 reporter, lineage tracing, mitotic index measurement, Neurog3 dose manipulation","journal":"Genes & development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — novel reporter system with quantitative mitotic and lineage readouts; single lab","pmids":["27585590"],"is_preprint":false},{"year":2017,"finding":"NEUROG3 is phosphorylated on serine 183 within the nucleus, which catalyzes its hyperphosphorylation and proteasomal degradation. This phosphorylation is driven by cyclin-dependent kinases 2 and 4/6 at the G1/S cell-cycle checkpoint. G1-phase lengthening in pancreatic progenitors stabilizes NEUROG3 and is essential for initiating endocrine differentiation.","method":"Phospho-specific antibodies, site-directed mutagenesis (S183), CDK inhibitor treatment, mouse and human pancreas development models, cell-cycle manipulation","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — phosphosite identified by mutagenesis, CDK writers identified by inhibition, functional consequence (protein stability and differentiation) demonstrated in both mouse and human models","pmids":["28441528"],"is_preprint":false},{"year":2017,"finding":"Nkx2.2 functions downstream of Neurog3: conditional ablation of Nkx2.2 specifically in the Neurog3+ endocrine progenitor lineage (using Neurog3-Cre) recapitulates the full Nkx2.2-null β-cell differentiation defect, demonstrating that Nkx2.2's essential activity for β-cell specification occurs within the Neurog3+ progenitor population.","method":"Conditional knockout using Neurog3-Cre, comparison of Nkx2.2 whole-body null vs. lineage-specific null phenotypes","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis using lineage-specific conditional KO; phenotypic comparison between whole-body and Neurog3-lineage-specific nulls definitively places Nkx2.2 downstream of Neurog3","pmids":["28071588"],"is_preprint":false},{"year":2018,"finding":"The ROCK-nmMyoII pathway coordinates epithelial morphogenesis with Neurog3 expression: nmMyoII is necessary for apical narrowing, basalward cell displacement, and Neurog3 transcriptional upregulation, but all three are limited by ROCK activity. Neurog3 protein is required for cell-rear detachment and complete endocrine-cell birth from the epithelial plexus.","method":"Pharmacological ROCK/nmMyoII inhibition, Neurog3-null analysis, live imaging of epithelial egression","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological manipulation and genetic null with morphogenetic and transcriptional readouts; single lab","pmids":["30126902"],"is_preprint":false},{"year":2018,"finding":"Hes1 loss causes ectopic pancreas through Neurog3-dependent mechanisms: genetic inactivation of Neurog3 in a Hes1-null background normalizes early pancreas morphogenesis and suppresses the ectopic pancreas phenotype, demonstrating that aberrant upregulation of Neurog3-driven endocrine differentiation drives the dysgenesis.","method":"Double mutant epistasis (Hes1-/-; Neurog3-/-), lineage tracing, live imaging, RNA-seq of sorted cells","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — double-mutant epistasis plus RNA-seq; rescue of morphogenetic phenotype by Neurog3 deletion firmly establishes pathway order","pmids":["30093553"],"is_preprint":false},{"year":2018,"finding":"NGN3 loss-of-function in pigs (CRISPR/Cas9 biallelic knockout) eliminates expression of downstream target genes NEUROD1 and PAX4, and abolishes insulin, glucagon, somatostatin, and pancreatic polypeptide-Y, confirming NGN3's conserved essential role in porcine endocrine pancreas development.","method":"CRISPR/Cas9 gene ablation in pigs, immunostaining and gene expression analysis of NGN3 knockout fetuses and neonates","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — complete in vivo knockout in large animal model with comprehensive hormone and target gene readout; multiple downstream targets confirmed absent","pmids":["29483633"],"is_preprint":false},{"year":2019,"finding":"Neurog3-independent DNA methylation at the Arx enhancer in pancreatic progenitors pre-specifies endocrine cell type fate: progenitors with higher Dnmt1 expression and Arx enhancer hypermethylation are biased toward β-cell fate, while those with lower methylation favor α-cell fate. This methylation state is established before Neurog3 activation and is not determined by Neurog3 itself.","method":"Single-cell RNA-seq, trajectory analysis, combinatorial lineage tracing (Myt1+Neurog3+ vs Myt1-Neurog3+), DNMT inhibition, Dnmt1 overexpression, targeted Arx enhancer methylation analysis","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal approaches (scRNA-seq, lineage tracing, epigenetic perturbation, locus-specific methylation) in single study; mechanistically distinguishes Neurog3-independent from Neurog3-dependent fate programs","pmids":["30620902"],"is_preprint":false},{"year":2021,"finding":"Genome-wide NEUROG3 occupancy mapping (CUT&RUN) in human iPSC-derived endocrine progenitors identified 863 binding sites assigned to 1263 genes, with a defined consensus NEUROG3 binding motif. NEUROG3 directly occupies promoters and enhancers of transcription factors essential for islet development (NEUROD1, PAX4, NKX2-2, SOX4, RFX3, NEUROG3 itself) and genes critical for beta-cell function (GCK, ABCC8/KCNJ11, CACNA1A, SLC30A8, PCSK1). 22% of genes downregulated in NEUROG3-/- progenitors are directly bound by NEUROG3.","method":"CUT&RUN chromatin occupancy mapping, hiPSC differentiation with HA-tagged NEUROG3, de novo motif analysis, integration with NEUROG3-/- transcriptomics","journal":"Molecular metabolism","confidence":"High","confidence_rationale":"Tier 1 / Strong — genome-wide direct binding mapped by CUT&RUN with HA-tagged endogenous NEUROG3; integrated with KO transcriptomics to distinguish direct from indirect targets; multiple orthogonal approaches","pmids":["34352411"],"is_preprint":false},{"year":2023,"finding":"USP7 (a deubiquitylating enzyme) physically interacts with, deubiquitinates, and stabilizes NGN3 protein. Conditional knockout of Usp7 in mouse embryonic pancreas dramatically reduces islet formation and causes adult hyperglycemia by impairing NGN3-mediated endocrine specification. Pharmacological inhibition of USP7 during human iPSC-derived beta-cell differentiation decreases NGN3+ progenitor numbers and impairs beta-cell differentiation.","method":"Binding partner screen, co-immunoprecipitation, deubiquitination assay, conditional Usp7 knockout in pancreas (Cre-lox), human iPSC differentiation with USP7 inhibitor","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — biochemical reconstitution of deubiquitination, reciprocal co-IP, in vivo conditional KO with islet phenotype, and human iPSC model; multiple orthogonal methods across mouse and human systems","pmids":["37117185"],"is_preprint":false},{"year":2025,"finding":"NGN3 protein oscillates with ~13-hour periodicity in human iPSC-derived endocrine progenitors and is extinguished upon differentiation. Stabilizing NGN3 protein (increasing protein stability) converts oscillations to a single broad peak and causes precocious endocrine differentiation and earlier expression of NGN3 target genes. Mathematical modeling and experimental validation indicate NGN3 oscillations are decoded via fold-change detection (FCD) through an incoherent feedforward loop (IFFL) motif.","method":"Knockin endogenous NGN3 reporter in hiPSCs, live imaging, protein stability manipulation, single-cell dynamics analysis, mathematical modeling","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — endogenous reporter quantifies protein dynamics; protein stabilization experiment demonstrates causal role of oscillation pattern; mathematical model validated experimentally; multiple orthogonal approaches","pmids":["40570854"],"is_preprint":false},{"year":2025,"finding":"NGN3 functions as a pioneer transcription factor that remodels chromatin accessibility during pancreatic endocrine differentiation. NGN3's pioneering function exhibits dose tolerance (low doses are sufficient). In the absence of NGN3, NEUROD1 can assume a pioneering role. Sequential expression of NeuroD1 before Ngn3 predominantly drives α-cell generation, explaining inefficient β-cell induction in certain in vitro contexts.","method":"Genetically engineered mouse model, NGN3 ChIP/binding site mapping, ATAC-seq (chromatin accessibility), manipulation of TF expression order","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 / Moderate — genome-wide chromatin accessibility (ATAC-seq) plus binding site mapping plus sequential expression manipulation; single lab but multiple orthogonal methods","pmids":["40138419"],"is_preprint":false},{"year":2010,"finding":"Ectopic Neurog3 in chicken endoderm requires full transcriptional activity for migration of electroporated cells: fusing Neurog3 to VP16 or co-electroporation with Ep300 (increased transcriptional activity) causes cells to migrate rather than differentiate, while reducing transcriptional activity (deletion of activation domain, engrailed repressor fusion, Hdac1 co-expression) greatly increases glucagon-expressing cell production.","method":"In ovo chicken endoderm electroporation, Neurog3 activation-domain deletion mutants, Neurog3-VP16 and Neurog3-EnR fusions, co-electroporation with Ep300 or Hdac1","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — structure-function analysis with multiple activation domain mutants in a defined in vivo assay; single lab","pmids":["20549731"],"is_preprint":false},{"year":2011,"finding":"E2f1 binds and activates the Ngn3 promoter in a Cdk4-dependent manner in the embryonic pancreas. Expression of activated Cdk4(R24C) kinase increases the number and proliferation of Ngn3+ endocrine precursors, leading to β-cell expansion.","method":"ChIP (E2f1 at Ngn3 promoter), Cdk4 knockout and Cdk4(R24C) gain-of-function mouse models, Ngn3+ cell quantification","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP demonstrates direct E2f1 binding at Ngn3 promoter; both loss-of-function and gain-of-function genetic models with quantitative endocrine precursor readout","pmids":["21490060"],"is_preprint":false},{"year":2004,"finding":"GDF11 (acting through SMAD2) negatively regulates the number of NGN3+ islet progenitor cells in the mouse pancreas. Gdf11-null mice have increased NGN3+ cell numbers but reduced beta-cell numbers, indicating GDF11/SMAD2 signaling controls both progenitor pool size and beta-cell maturation downstream or in parallel with Notch pathway regulation of NGN3+ cells.","method":"Gdf11-null and Smad2-null mouse analysis, NGN3+ cell quantification, beta-cell counting","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent genetic loss-of-function models (Gdf11-/-, Smad2-/-) with consistent NGN3+ progenitor expansion phenotype","pmids":["15548585"],"is_preprint":false}],"current_model":"NEUROG3 is a bHLH transcription factor that acts as the master regulator of pancreatic and intestinal endocrine lineage specification: it is transcriptionally activated by upstream regulators (HNF-6/ONECUT1, HNF1B, E2F1/CDK4, STAT3) and its protein levels are tightly controlled post-translationally by CDK2/4/6-driven phosphorylation on S183 (promoting proteasomal degradation), Notch/Hes1-mediated destabilization, and USP7-mediated deubiquitination and stabilization; in human progenitors NGN3 protein oscillates (~13h periodicity) with oscillatory dynamics decoded by fold-change detection to control differentiation timing; as a pioneer transcription factor it remodels chromatin and directly occupies hundreds of target gene loci (NEUROD1, PAX4, NKX2-2, GCK, ABCC8, RFX3, and many others) to initiate the endocrine gene program, while cell-extrinsically activating Dll1>Notch>Hes1 lateral inhibition to limit the number of cells undergoing endocrine commitment; the threshold level of NEUROG3 determines cell fate allocation (high levels drive endocrine commitment; low levels allow ductal/acinar fates), and sustained NEUROG3 expression in hormone-expressing islet cells continues to be required for islet maturation and function beyond the initial progenitor specification event."},"narrative":{"mechanistic_narrative":"NEUROG3 (NGN3) is a basic helix-loop-helix transcription factor that acts as the master initiator of endocrine lineage specification in the pancreas and intestine [PMID:20025861, PMID:25650326]. Its expression is set by a hierarchy of direct upstream activators that bind its promoter/enhancer — HNF-6/ONECUT1 [PMID:10825208], HNF1B [PMID:25715395], E2F1 acting in a CDK4-dependent manner [PMID:21490060], and STAT3 in response to inflammatory cytokines and in non-pancreatic contexts [PMID:22378757, PMID:27068459] — while GDF11/SMAD2 signaling restrains the size of the NGN3+ progenitor pool [PMID:15548585]. Functioning as a pioneer transcription factor, NGN3 remodels chromatin accessibility and directly occupies promoters and enhancers of hundreds of target genes, including the endocrine transcription factors NEUROD1, PAX4, NKX2-2, RFX6/RFX3 and INSM2, and beta-cell functional genes such as GCK and ABCC8, thereby launching the islet gene program [PMID:16511571, PMID:20040487, PMID:21343251, PMID:34352411, PMID:40138419]. Cell-fate output is dose-dependent: high NGN3 drives endocrine commitment whereas low levels permit ductal/acinar fates [PMID:20025861, PMID:25650326], and its pioneering activity is dose-tolerant such that NEUROD1 can substitute when NGN3 is absent, with the order of factor expression biasing alpha- versus beta-cell production [PMID:40138419]. NGN3 protein abundance is tightly controlled post-translationally: CDK2/4/6 phosphorylate serine 183 to trigger proteasomal degradation, coupling endocrine differentiation to G1-phase lengthening [PMID:28441528]; Notch/Hes1 signaling destabilizes the protein [PMID:23370147]; and USP7 deubiquitinates and stabilizes it [PMID:37117185]. In human progenitors NGN3 protein oscillates with ~13-hour periodicity, and these dynamics are decoded by fold-change detection through an incoherent feedforward loop to time differentiation [PMID:40570854]. NGN3 in turn activates Dll1>Notch>Hes1 lateral inhibition to limit the number of cells entering the endocrine program and shape duct morphogenesis [PMID:21888903, PMID:23370147, PMID:30093553], and it is required for epithelial egression of nascent endocrine cells [PMID:30126902]. Beyond initial specification, sustained NGN3 in hormone-expressing islet cells is needed for islet maturation and function [PMID:19487660]. Biallelic loss-of-function mutations in human NEUROG3 cause neonatal diabetes with absent enteroendocrine cells [PMID:21378176].","teleology":[{"year":2000,"claim":"Establishing how Neurog3 is switched on, HNF-6 was identified as the first direct upstream activator, anchoring the gene in a transcriptional hierarchy rather than acting in isolation.","evidence":"Promoter binding assay and hnf6-/- mouse with loss of Ngn3 expression","pmids":["10825208"],"confidence":"High","gaps":["Did not identify the full set of cofactors at the Ngn3 promoter","Did not address post-transcriptional control of Ngn3"]},{"year":2004,"claim":"GDF11/SMAD2 signaling was shown to set the size of the NGN3+ progenitor pool, identifying an extrinsic brake on endocrine progenitor number.","evidence":"Gdf11-null and Smad2-null mice with progenitor quantification","pmids":["15548585"],"confidence":"High","gaps":["Mechanistic link to Notch regulation only inferred","Did not define whether effect is on NGN3 transcription or progenitor proliferation"]},{"year":2006,"claim":"Direct chromatin binding at IA1, validated by epistasis against downstream factors, moved NGN3 from a presumed regulator to a demonstrated direct activator of early endocrine target genes.","evidence":"ChIP and ectopic expression in duct cells with genetic epistasis across multiple TF mutants","pmids":["16511571"],"confidence":"High","gaps":["Single target locus, not genome-wide","Did not define cofactor requirements for activation"]},{"year":2008,"claim":"The mismatch between widespread Ngn3 mRNA and restricted protein revealed that post-transcriptional control, not just transcription, governs where NGN3 acts.","evidence":"Parallel mRNA in situ and protein immunofluorescence across embryogenesis; plus Myt1b/Ngn3 feed-forward loop by epistasis","pmids":["18924236","18394599"],"confidence":"Medium","gaps":["Molecular mechanism of protein restriction not identified in these studies","Single-lab observations"]},{"year":2009,"claim":"Gene-dosage and conditional studies established that NGN3 level is a fate determinant and that its requirement extends beyond progenitor specification into islet maturation.","evidence":"Allelic dosage series with lineage tracking; conditional KO in hormone+ cells with reporter lines","pmids":["20025861","19487660"],"confidence":"High","gaps":["Did not define the molecular threshold sensor","Mechanism of sustained maturation role left open"]},{"year":2010,"claim":"Defining the target hierarchy and the role of transcriptional activity, Rfx6 was placed directly downstream and NGN3's activation-domain strength was shown to switch cells between migration and differentiation.","evidence":"Epistasis in mutant embryos plus zebrafish loss-of-function; activation-domain mutant and VP16/EnR fusions in chick electroporation","pmids":["20040487","20549731"],"confidence":"High","gaps":["Coactivators bridging NGN3 to target promoters not yet identified","Migration-versus-differentiation switch mechanism unresolved"]},{"year":2011,"claim":"Multiple studies cemented NGN3's direct target repertoire (Insm2), its requirement in humans, and its non-cell-autonomous role in feeding back via Notch to shape duct morphogenesis and limit endocrine commitment.","evidence":"ChIP and promoter mutagenesis (Insm2); human patient mutations with E-box binding and chick electroporation assays; Ngn3-null/gain-of-function morphogenesis; E2f1/Cdk4-dependent promoter activation","pmids":["21343251","21378176","21888903","21490060","21383077"],"confidence":"High","gaps":["Direct ligand/receptor mediating the feedback signal not fully resolved","Genome-wide binding map still lacking at this point"]},{"year":2012,"claim":"A coactivator (CCAR1) and a context-specific upstream activator (STAT3 in spermatogonia) extended the regulatory and functional network around NGN3 beyond the pancreas.","evidence":"Reciprocal Co-IP/pull-down and reporter/knockdown for CCAR1; ChIP and RNAi/transplantation for STAT3","pmids":["22266316","22378757"],"confidence":"Medium","gaps":["CCAR1 interaction from single lab without structural detail","Role of NGN3 outside endocrine tissues incompletely defined"]},{"year":2013,"claim":"Notch was shown to control NGN3 post-translationally by destabilizing the protein, distinguishing transcriptional from protein-level regulation in the lateral-inhibition circuit.","evidence":"Notch inhibition of pancreas explants with protein stability readout; conditional Ngn3 expression","pmids":["23370147"],"confidence":"Medium","gaps":["Did not identify the degradation machinery","Single-lab pharmacological approach"]},{"year":2014,"claim":"Insm1 was found to support correct Neurog3 mRNA splicing/expression, adding an RNA-level layer to NGN3 control during progenitor differentiation.","evidence":"Insm1-null reporter mouse with transcriptomic analysis of progenitors","pmids":["25053427"],"confidence":"Medium","gaps":["Direct splicing mechanism not demonstrated","Single-lab study"]},{"year":2015,"claim":"Human genetic and stem-cell models established the conserved, dose-dependent requirement of NEUROG3 for human endocrine development, and Hnf1b was confirmed as a direct upstream regulator.","evidence":"CRISPR knockout and knockdown titration in hESCs with in vitro/engraftment readouts; conditional Hnf1b KO with ChIP at Ngn3 locus","pmids":["25650326","25715395"],"confidence":"High","gaps":["Why as little as 10% NGN3 suffices not mechanistically explained","Did not map genome-wide NGN3 targets in human cells"]},{"year":2016,"claim":"Inflammatory STAT3 signaling was shown to reactivate NGN3 and drive ductal-to-endocrine reprogramming, and a transcriptionally-active but low-protein progenitor state was defined, linking NGN3 level to proliferative versus committed states.","evidence":"Cytokine/STAT3 manipulation in ductal cells and NOD mice; BAC reporter with lineage tracing and mitotic index","pmids":["27068459","27585590"],"confidence":"Medium","gaps":["Stability of reprogrammed endocrine cells not established","Single-lab reporter system"]},{"year":2017,"claim":"The S183 phosphodegron and its CDK2/4/6 writers were identified, mechanistically coupling NGN3 protein stability to cell-cycle state and explaining how G1 lengthening initiates differentiation; Nkx2.2 was placed downstream within the NGN3 lineage.","evidence":"Phospho-specific antibodies, S183 mutagenesis, CDK inhibition in mouse/human models; Neurog3-Cre lineage-specific Nkx2.2 KO","pmids":["28441528","28071588"],"confidence":"High","gaps":["E3 ligase mediating S183-dependent degradation not identified here","Did not address deubiquitination counterbalance"]},{"year":2018,"claim":"Studies connected NGN3 to epithelial morphogenesis and established it as the effector driving Hes1-loss dysgenesis, showing NGN3 both responds to and remodels tissue architecture.","evidence":"ROCK/nmMyoII inhibition with live imaging and Ngn3-null; Hes1-/-;Neurog3-/- double-mutant epistasis with RNA-seq","pmids":["30126902","30093553"],"confidence":"High","gaps":["Direct molecular link between NGN3 and the cell-detachment machinery undefined","Morphogenetic role single-lab for nmMyoII arm"]},{"year":2019,"claim":"An NGN3-independent epigenetic prepattern (Arx enhancer methylation) was shown to bias alpha- versus beta-cell fate before NGN3 acts, delineating the boundary of NGN3's instructive role.","evidence":"scRNA-seq, combinatorial lineage tracing, DNMT perturbation, locus-specific methylation analysis","pmids":["30620902"],"confidence":"High","gaps":["How NGN3 integrates with the pre-set methylation state not resolved","Upstream determinant of differential Dnmt1 levels unknown"]},{"year":2021,"claim":"Genome-wide occupancy mapping in human progenitors converted the piecemeal target list into a defined direct regulatory network and consensus motif, distinguishing direct from indirect targets.","evidence":"CUT&RUN with HA-tagged NEUROG3 in hiPSC progenitors integrated with NEUROG3-/- transcriptomics","pmids":["34352411"],"confidence":"High","gaps":["Functional weight of individual binding sites untested","Did not directly demonstrate chromatin remodeling at bound sites"]},{"year":2023,"claim":"USP7 was identified as the deubiquitinase that stabilizes NGN3, providing the counterweight to phosphodegron-driven turnover and a tractable node for controlling endocrine specification.","evidence":"Co-IP, deubiquitination assay, conditional Usp7 pancreas KO, and USP7 inhibition in human iPSC beta-cell differentiation","pmids":["37117185"],"confidence":"High","gaps":["The cognate E3 ubiquitin ligase opposing USP7 not identified","Coupling between USP7 and S183 phosphorylation not resolved"]},{"year":2025,"claim":"NGN3 protein dynamics and chromatin function were defined: ~13h oscillations decoded by fold-change detection time differentiation, and NGN3 acts as a dose-tolerant pioneer factor whose expression order with NeuroD1 dictates alpha/beta-cell output.","evidence":"Endogenous knockin reporter with live imaging, protein stabilization, and mathematical modeling; ATAC-seq, binding mapping and sequential TF expression in mouse model","pmids":["40570854","40138419"],"confidence":"High","gaps":["Molecular machinery generating the oscillation not fully defined","How fold-change is sensed at the chromatin level unresolved"]},{"year":null,"claim":"The full degradation machinery (E3 ligase) acting on phospho-S183 NGN3, and how oscillatory protein dynamics are mechanistically read out at target chromatin to set the differentiation threshold, remain open.","evidence":"","pmids":[],"confidence":"High","gaps":["No E3 ligase opposing USP7 identified","Chromatin-level decoder of fold-change detection unknown","Quantitative link between protein threshold and individual target activation undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,7,25,28]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[1,7,10,25,28]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[19]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[1,25,28]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5,15,23]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[28]}],"complexes":[],"partners":["CCAR1","USP7"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9Y4Z2","full_name":"Neurogenin-3","aliases":["Class A basic helix-loop-helix protein 7","bHLHa7","Protein atonal homolog 5"],"length_aa":214,"mass_kda":23.1,"function":"Is a transcriptional regulator involved in the control of enteroendocrine cell differentiation (PubMed:21378176). Together with NKX2-2, initiates transcriptional activation of NEUROD1 (PubMed:16855267, PubMed:21378176). Involved in neurogenesis. Also required for the specification of a common precursor of the 4 pancreatic endocrine cell types (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9Y4Z2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NEUROG3","classification":"Not Classified","n_dependent_lines":34,"n_total_lines":1208,"dependency_fraction":0.028145695364238412},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NEUROG3","total_profiled":1310},"omim":[{"mim_id":"619820","title":"ATONAL bHLH TRANSCRIPTION FACTOR 8; ATOH8","url":"https://www.omim.org/entry/619820"},{"mim_id":"614027","title":"INSULINOMA-ASSOCIATED 2; INSM2","url":"https://www.omim.org/entry/614027"},{"mim_id":"612659","title":"REGULATORY FACTOR X, 6; RFX6","url":"https://www.omim.org/entry/612659"},{"mim_id":"610370","title":"DIARRHEA 4, MALABSORPTIVE, CONGENITAL, WITH DIABETES MELLITUS AND COMBINED PITUITARY HORMONE DEFICIENCY; DIAR4","url":"https://www.omim.org/entry/610370"},{"mim_id":"610303","title":"MAF bZIP TRANSCRIPTION FACTOR A; MAFA","url":"https://www.omim.org/entry/610303"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nuclear speckles","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":2.3},{"tissue":"intestine","ntpm":2.4}],"url":"https://www.proteinatlas.org/search/NEUROG3"},"hgnc":{"alias_symbol":["Atoh5","Math4B","ngn3","bHLHa7"],"prev_symbol":[]},"alphafold":{"accession":"Q9Y4Z2","domains":[{"cath_id":"4.10.280,4.10.280","chopping":"75-149","consensus_level":"medium","plddt":95.0032,"start":75,"end":149}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y4Z2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y4Z2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y4Z2-F1-predicted_aligned_error_v6.png","plddt_mean":69.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NEUROG3","jax_strain_url":"https://www.jax.org/strain/search?query=NEUROG3"},"sequence":{"accession":"Q9Y4Z2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y4Z2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y4Z2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y4Z2"}},"corpus_meta":[{"pmid":"21383077","id":"PMC_21383077","title":"Distinct ATOH1 and Neurog3 requirements define tuft cells as a new secretory cell type in the intestinal epithelium.","date":"2011","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21383077","citation_count":319,"is_preprint":false},{"pmid":"10825208","id":"PMC_10825208","title":"Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine gene ngn3.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10825208","citation_count":275,"is_preprint":false},{"pmid":"28235195","id":"PMC_28235195","title":"Fasting-Mimicking Diet Promotes Ngn3-Driven β-Cell Regeneration to Reverse Diabetes.","date":"2017","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/28235195","citation_count":264,"is_preprint":false},{"pmid":"28071588","id":"PMC_28071588","title":"Genetic evidence that Nkx2.2 acts primarily downstream of Neurog3 in pancreatic endocrine lineage development.","date":"2017","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/28071588","citation_count":156,"is_preprint":false},{"pmid":"15793239","id":"PMC_15793239","title":"PDX-1/VP16 fusion protein, together with NeuroD or Ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance.","date":"2005","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/15793239","citation_count":151,"is_preprint":false},{"pmid":"16511571","id":"PMC_16511571","title":"IA1 is NGN3-dependent and essential for differentiation of the endocrine pancreas.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16511571","citation_count":149,"is_preprint":false},{"pmid":"19487660","id":"PMC_19487660","title":"Sustained Neurog3 expression in hormone-expressing islet cells is required for endocrine maturation and function.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19487660","citation_count":142,"is_preprint":false},{"pmid":"15548585","id":"PMC_15548585","title":"GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentiation in pancreas development.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15548585","citation_count":134,"is_preprint":false},{"pmid":"20040487","id":"PMC_20040487","title":"Rfx6 is an Ngn3-dependent winged helix transcription factor required for pancreatic islet cell development.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20040487","citation_count":126,"is_preprint":false},{"pmid":"21378176","id":"PMC_21378176","title":"Permanent Neonatal Diabetes and Enteric Anendocrinosis Associated With Biallelic Mutations in NEUROG3.","date":"2011","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/21378176","citation_count":116,"is_preprint":false},{"pmid":"18924236","id":"PMC_18924236","title":"Biphasic Ngn3 expression in the developing pancreas.","date":"2008","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/18924236","citation_count":112,"is_preprint":false},{"pmid":"20025861","id":"PMC_20025861","title":"Neurog3 gene dosage regulates allocation of endocrine and exocrine cell fates in the developing mouse pancreas.","date":"2009","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/20025861","citation_count":110,"is_preprint":false},{"pmid":"25715395","id":"PMC_25715395","title":"Hnf1b controls pancreas morphogenesis and the generation of Ngn3+ endocrine progenitors.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25715395","citation_count":103,"is_preprint":false},{"pmid":"25650326","id":"PMC_25650326","title":"The Basic Helix-Loop-Helix Transcription Factor NEUROG3 Is Required for Development of the Human Endocrine Pancreas.","date":"2015","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/25650326","citation_count":92,"is_preprint":false},{"pmid":"22150363","id":"PMC_22150363","title":"Reprogramming of pancreatic exocrine cells towards a beta (β) cell character using Pdx1, Ngn3 and MafA.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22150363","citation_count":88,"is_preprint":false},{"pmid":"18394599","id":"PMC_18394599","title":"Myt1 and Ngn3 form a feed-forward expression loop to promote endocrine islet cell differentiation.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18394599","citation_count":74,"is_preprint":false},{"pmid":"34478642","id":"PMC_34478642","title":"Ductal Ngn3-expressing progenitors contribute to adult β cell neogenesis in the pancreas.","date":"2021","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/34478642","citation_count":73,"is_preprint":false},{"pmid":"28441528","id":"PMC_28441528","title":"Phosphorylation of NEUROG3 Links Endocrine Differentiation to the Cell Cycle in Pancreatic Progenitors.","date":"2017","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/28441528","citation_count":71,"is_preprint":false},{"pmid":"16514419","id":"PMC_16514419","title":"Ngn3 expression during postnatal in vitro beta cell neogenesis induced by the JAK/STAT pathway.","date":"2006","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/16514419","citation_count":69,"is_preprint":false},{"pmid":"15652518","id":"PMC_15652518","title":"Enhanced expression of PDX-1 and Ngn3 by exendin-4 during beta cell regeneration in STZ-treated mice.","date":"2005","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/15652518","citation_count":67,"is_preprint":false},{"pmid":"22378757","id":"PMC_22378757","title":"NEUROG3 is a critical downstream effector for STAT3-regulated differentiation of mammalian stem and progenitor spermatogonia.","date":"2012","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/22378757","citation_count":64,"is_preprint":false},{"pmid":"27068459","id":"PMC_27068459","title":"Proinflammatory Cytokines Induce Endocrine Differentiation in Pancreatic Ductal Cells via STAT3-Dependent NGN3 Activation.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27068459","citation_count":62,"is_preprint":false},{"pmid":"21888903","id":"PMC_21888903","title":"Ngn3(+) endocrine progenitor cells control the fate and morphogenesis of pancreatic ductal epithelium.","date":"2011","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/21888903","citation_count":60,"is_preprint":false},{"pmid":"25053427","id":"PMC_25053427","title":"Insm1 promotes endocrine cell differentiation by modulating the expression of a network of genes that includes Neurog3 and Ripply3.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25053427","citation_count":58,"is_preprint":false},{"pmid":"21739268","id":"PMC_21739268","title":"Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2.","date":"2011","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21739268","citation_count":54,"is_preprint":false},{"pmid":"27585590","id":"PMC_27585590","title":"Precommitment low-level Neurog3 expression defines a long-lived mitotic endocrine-biased progenitor pool that drives production of endocrine-committed cells.","date":"2016","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/27585590","citation_count":52,"is_preprint":false},{"pmid":"17932425","id":"PMC_17932425","title":"Novel effectors of directed and Ngn3-mediated differentiation of mouse embryonic stem cells into endocrine pancreas progenitors.","date":"2007","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/17932425","citation_count":49,"is_preprint":false},{"pmid":"23370147","id":"PMC_23370147","title":"Notch-mediated post-translational control of Ngn3 protein stability regulates pancreatic patterning and cell fate commitment.","date":"2013","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23370147","citation_count":44,"is_preprint":false},{"pmid":"34004210","id":"PMC_34004210","title":"Breast milk MSCs upregulated β-cells PDX1, Ngn3, and PCNA expression via remodeling ER stress /inflammatory /apoptotic signaling pathways in type 1 diabetic rats.","date":"2021","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34004210","citation_count":42,"is_preprint":false},{"pmid":"30620902","id":"PMC_30620902","title":"Neurog3-Independent Methylation Is the Earliest Detectable Mark Distinguishing Pancreatic Progenitor Identity.","date":"2019","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/30620902","citation_count":40,"is_preprint":false},{"pmid":"21931641","id":"PMC_21931641","title":"Pdx1 and Ngn3 overexpression enhances pancreatic differentiation of mouse ES cell-derived endoderm population.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21931641","citation_count":38,"is_preprint":false},{"pmid":"21490060","id":"PMC_21490060","title":"The Cdk4-E2f1 pathway regulates early pancreas development by targeting Pdx1+ progenitors and Ngn3+ endocrine precursors.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21490060","citation_count":37,"is_preprint":false},{"pmid":"24312421","id":"PMC_24312421","title":"Reprogramming of various cell types to a beta-like state by Pdx1, Ngn3 and MafA.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24312421","citation_count":35,"is_preprint":false},{"pmid":"21506889","id":"PMC_21506889","title":"PDX1- and NGN3-mediated in vitro reprogramming of human bone marrow-derived mesenchymal stromal cells into pancreatic endocrine lineages.","date":"2011","source":"Cytotherapy","url":"https://pubmed.ncbi.nlm.nih.gov/21506889","citation_count":35,"is_preprint":false},{"pmid":"23835295","id":"PMC_23835295","title":"Ascl1b and Neurod1, instead of Neurog3, control pancreatic endocrine cell fate in zebrafish.","date":"2013","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/23835295","citation_count":34,"is_preprint":false},{"pmid":"19913512","id":"PMC_19913512","title":"5'-AZA induces Ngn3 expression and endocrine differentiation in the PANC-1 human ductal cell line.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19913512","citation_count":32,"is_preprint":false},{"pmid":"18599526","id":"PMC_18599526","title":"Mouse pancreatic endocrine cell transcriptome defined in the embryonic Ngn3-null mouse.","date":"2008","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/18599526","citation_count":31,"is_preprint":false},{"pmid":"34352411","id":"PMC_34352411","title":"Extensive NEUROG3 occupancy in the human pancreatic endocrine gene regulatory network.","date":"2021","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34352411","citation_count":28,"is_preprint":false},{"pmid":"21734788","id":"PMC_21734788","title":"Streptozotocin-induced expression of Ngn3 and Pax4 in neonatal rat pancreatic α-cells.","date":"2011","source":"World journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/21734788","citation_count":28,"is_preprint":false},{"pmid":"22776709","id":"PMC_22776709","title":"The combined expression of Pdx1 and MafA with either Ngn3 or NeuroD improves the differentiation efficiency of mouse embryonic stem cells into insulin-producing cells.","date":"2012","source":"Cell transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/22776709","citation_count":28,"is_preprint":false},{"pmid":"27187823","id":"PMC_27187823","title":"Reprogramming of Pancreatic Exocrine Cells AR42J Into Insulin-producing Cells Using mRNAs for Pdx1, Ngn3, and MafA Transcription Factors.","date":"2016","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/27187823","citation_count":27,"is_preprint":false},{"pmid":"37028408","id":"PMC_37028408","title":"Matters arising: Insufficient evidence that pancreatic β cells are derived from adult ductal Neurog3-expressing progenitors.","date":"2023","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/37028408","citation_count":23,"is_preprint":false},{"pmid":"29483633","id":"PMC_29483633","title":"Targeted Mutation of NGN3 Gene Disrupts Pancreatic Endocrine Cell Development in Pigs.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29483633","citation_count":23,"is_preprint":false},{"pmid":"25715394","id":"PMC_25715394","title":"Bicaudal C1 promotes pancreatic NEUROG3+ endocrine progenitor differentiation and ductal morphogenesis.","date":"2015","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25715394","citation_count":23,"is_preprint":false},{"pmid":"24493854","id":"PMC_24493854","title":"Prospectively isolated NGN3-expressing progenitors from human embryonic stem cells give rise to pancreatic endocrine cells.","date":"2014","source":"Stem cells translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24493854","citation_count":20,"is_preprint":false},{"pmid":"20807725","id":"PMC_20807725","title":"In vitro expression of NGN3 identifies RAB3B as the predominant Ras-associated GTP-binding protein 3 family member in human islets.","date":"2010","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/20807725","citation_count":20,"is_preprint":false},{"pmid":"32822913","id":"PMC_32822913","title":"Reduced Neurog3 Gene Dosage Shifts Enteroendocrine Progenitor Towards Goblet Cell Lineage in the Mouse Intestine.","date":"2020","source":"Cellular and molecular gastroenterology and hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/32822913","citation_count":19,"is_preprint":false},{"pmid":"30126902","id":"PMC_30126902","title":"ROCK-nmMyoII, Notch and Neurog3 gene-dosage link epithelial morphogenesis with cell fate in the pancreatic endocrine-progenitor niche.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30126902","citation_count":17,"is_preprint":false},{"pmid":"27786288","id":"PMC_27786288","title":"An inhibitor of fibroblast growth factor receptor-1 (FGFR1) promotes late-stage terminal differentiation from NGN3+ pancreatic endocrine progenitors.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27786288","citation_count":16,"is_preprint":false},{"pmid":"28940958","id":"PMC_28940958","title":"A novel NEUROG3 mutation in neonatal diabetes associated with a neuro-intestinal syndrome.","date":"2017","source":"Pediatric diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/28940958","citation_count":15,"is_preprint":false},{"pmid":"21343251","id":"PMC_21343251","title":"Expression of insulinoma-associated 2 (INSM2) in pancreatic islet cells is regulated by the transcription factors Ngn3 and NeuroD1.","date":"2011","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21343251","citation_count":15,"is_preprint":false},{"pmid":"26345820","id":"PMC_26345820","title":"Pdxl and its role in activating Ngn3 and Pax6 to induce differentiation of iPSCs into islet β cells.","date":"2015","source":"Genetics and molecular research : GMR","url":"https://pubmed.ncbi.nlm.nih.gov/26345820","citation_count":14,"is_preprint":false},{"pmid":"31572507","id":"PMC_31572507","title":"Pax4 synergistically acts with Pdx1, Ngn3 and MafA to induce HuMSCs to differentiate into functional pancreatic β-cells.","date":"2019","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31572507","citation_count":14,"is_preprint":false},{"pmid":"37117185","id":"PMC_37117185","title":"USP7 controls NGN3 stability and pancreatic endocrine lineage development.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37117185","citation_count":13,"is_preprint":false},{"pmid":"32427857","id":"PMC_32427857","title":"Estradiol-dependent axogenesis and Ngn3 expression are determined by XY sex chromosome complement in hypothalamic neurons.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32427857","citation_count":13,"is_preprint":false},{"pmid":"11246894","id":"PMC_11246894","title":"Mutations in the coding region of the neurogenin 3 gene (NEUROG3) are not a common cause of maturity-onset diabetes of the young in Japanese subjects.","date":"2001","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/11246894","citation_count":13,"is_preprint":false},{"pmid":"31805014","id":"PMC_31805014","title":"Null mutations of NEUROG3 are associated with delayed-onset diabetes mellitus.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/31805014","citation_count":12,"is_preprint":false},{"pmid":"30093553","id":"PMC_30093553","title":"Neurog3-dependent pancreas dysgenesis causes ectopic pancreas in Hes1 mutant mice.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30093553","citation_count":12,"is_preprint":false},{"pmid":"22121111","id":"PMC_22121111","title":"Transient expression of Ngn3 in Xenopus endoderm promotes early and ectopic development of pancreatic beta and delta cells.","date":"2012","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/22121111","citation_count":12,"is_preprint":false},{"pmid":"22266316","id":"PMC_22266316","title":"CCAR1 is required for Ngn3-mediated endocrine differentiation.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22266316","citation_count":11,"is_preprint":false},{"pmid":"36140793","id":"PMC_36140793","title":"Expression Profiling of Pdx1, Ngn3, and MafA in the Liver and Pancreas of Recovering Streptozotocin-Induced Diabetic Rats.","date":"2022","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/36140793","citation_count":10,"is_preprint":false},{"pmid":"40570854","id":"PMC_40570854","title":"NGN3 oscillatory expression controls the timing of human pancreatic endocrine differentiation.","date":"2025","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/40570854","citation_count":9,"is_preprint":false},{"pmid":"24450812","id":"PMC_24450812","title":"Expression pattern of Ngn3 in dairy goat testis and its function in promoting meiosis by upregulating Stra8.","date":"2013","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/24450812","citation_count":9,"is_preprint":false},{"pmid":"17146417","id":"PMC_17146417","title":"NEUROG3 variants and type 2 diabetes in Italians.","date":"2006","source":"Minerva medica","url":"https://pubmed.ncbi.nlm.nih.gov/17146417","citation_count":9,"is_preprint":false},{"pmid":"20549731","id":"PMC_20549731","title":"The transcriptional activity of Neurog3 affects migration and differentiation of ectopic endocrine cells in chicken endoderm.","date":"2010","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/20549731","citation_count":8,"is_preprint":false},{"pmid":"38871849","id":"PMC_38871849","title":"Forward programming of hiPSCs towards beta-like cells using Ngn3, Pdx1, and MafA.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38871849","citation_count":7,"is_preprint":false},{"pmid":"36209951","id":"PMC_36209951","title":"Carob extract induces spermatogenesis in an infertile mouse model via upregulation of Prm1, Plzf, Bcl-6b, Dazl, Ngn3, Stra8, and Smc1b.","date":"2022","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36209951","citation_count":7,"is_preprint":false},{"pmid":"28966671","id":"PMC_28966671","title":"Pancreatic islet regeneration through PDX-1/Notch-1/Ngn3 signaling after gastric bypass surgery in db/db mice.","date":"2017","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28966671","citation_count":7,"is_preprint":false},{"pmid":"28152182","id":"PMC_28152182","title":"Reprogramming of Pancreatic Acinar Cells to Functional Beta Cells by In Vivo Transduction of a Polycistronic Construct Containing Pdx1, Ngn3, MafA in Mice.","date":"2017","source":"Current protocols in stem cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/28152182","citation_count":7,"is_preprint":false},{"pmid":"36149814","id":"PMC_36149814","title":"Novel Variants and Phenotypes in NEUROG3-Associated Syndrome.","date":"2022","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/36149814","citation_count":6,"is_preprint":false},{"pmid":"33878431","id":"PMC_33878431","title":"Effect of NEUROG3 polymorphism rs144643855 on regional spontaneous brain activity in major depressive disorder.","date":"2021","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/33878431","citation_count":6,"is_preprint":false},{"pmid":"30092080","id":"PMC_30092080","title":"Neurog3 misexpression unravels mouse pancreatic ductal cell plasticity.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30092080","citation_count":6,"is_preprint":false},{"pmid":"40138419","id":"PMC_40138419","title":"The expression order determines the pioneer functions of NGN3 and NEUROD1 in pancreatic endocrine differentiation.","date":"2025","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/40138419","citation_count":5,"is_preprint":false},{"pmid":"34445257","id":"PMC_34445257","title":"Ngn3-Positive Cells Arise from Pancreatic Duct Cells.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34445257","citation_count":5,"is_preprint":false},{"pmid":"38227487","id":"PMC_38227487","title":"A hydrolyzed casein diet promotes Ngn3 controlling enteroendocrine cell differentiation to increase gastrointestinal motility in mice.","date":"2024","source":"Food & function","url":"https://pubmed.ncbi.nlm.nih.gov/38227487","citation_count":5,"is_preprint":false},{"pmid":"28921917","id":"PMC_28921917","title":"Changes on the Pancreas in Experimental Diabetes and the Effect of Lycopene on These Changes: Pdx-1, Ngn-3, and Nestin Expressions.","date":"2017","source":"Anatomical record (Hoboken, N.J. : 2007)","url":"https://pubmed.ncbi.nlm.nih.gov/28921917","citation_count":5,"is_preprint":false},{"pmid":"17706592","id":"PMC_17706592","title":"Co-expressing Pdx1 and Ngn3 induces few beta-like cells in the liver of mice.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17706592","citation_count":4,"is_preprint":false},{"pmid":"27836003","id":"PMC_27836003","title":"Adult human pancreas-derived cells expressing stage-specific embryonic antigen 4 differentiate into Sox9-expressing and Ngn3-expressing pancreatic ducts in vivo.","date":"2016","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/27836003","citation_count":4,"is_preprint":false},{"pmid":"19108739","id":"PMC_19108739","title":"Bipotential mouse embryonic liver (BMEL) cells spontaneously express Pdx1 and Ngn3 but do not undergo further pancreatic differentiation upon Hes1 down-regulation.","date":"2008","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/19108739","citation_count":4,"is_preprint":false},{"pmid":"28772022","id":"PMC_28772022","title":"FUCCI tracking shows cell-cycle-dependent Neurog3 variation in pancreatic progenitors.","date":"2017","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/28772022","citation_count":3,"is_preprint":false},{"pmid":"40205162","id":"PMC_40205162","title":"Ductal or Ngn3+ cells do not contribute to adult pancreatic islet beta-cell neogenesis in homeostasis.","date":"2025","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/40205162","citation_count":3,"is_preprint":false},{"pmid":"34550497","id":"PMC_34550497","title":"Protein Production and Purification of a Codon-Optimized Human NGN3 Transcription Factor from E. coli.","date":"2021","source":"The protein journal","url":"https://pubmed.ncbi.nlm.nih.gov/34550497","citation_count":3,"is_preprint":false},{"pmid":"21294959","id":"PMC_21294959","title":"Pdx1- and Ngn3-Cre-mediated PLAG1 expression in the pancreas leads to endocrine hormone imbalances that affect glucose metabolism.","date":"2011","source":"Cell transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/21294959","citation_count":3,"is_preprint":false},{"pmid":"35236160","id":"PMC_35236160","title":"The Roles of Different Multigene Combinations of Pdx1, Ngn3, Sox9, Pax4, and Nkx2.2 in the Reprogramming of Canine ADSCs Into IPCs.","date":"2022","source":"Cell transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/35236160","citation_count":3,"is_preprint":false},{"pmid":"32179491","id":"PMC_32179491","title":"Transient FOXO1 inhibition in pancreatic endoderm promotes the generation of NGN3+ endocrine precursors from human iPSCs.","date":"2020","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/32179491","citation_count":2,"is_preprint":false},{"pmid":"37098639","id":"PMC_37098639","title":"Single-cell transcriptome analysis of NEUROG3+ cells during pancreatic endocrine differentiation with small molecules.","date":"2023","source":"Stem cell research & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37098639","citation_count":1,"is_preprint":false},{"pmid":"20575431","id":"PMC_20575431","title":"[Construction and identification of recombinant retroviral vector of human ngn3 gene and its packaging cell line].","date":"2010","source":"Sheng wu gong cheng xue bao = Chinese journal of biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/20575431","citation_count":1,"is_preprint":false},{"pmid":"40834996","id":"PMC_40834996","title":"Innovative therapeutic modalities of purified platelet-derived growth factors on PDX1, Neurog3, and renin expressions in STZ-induced diabetic nephropathy and pancreatic injury.","date":"2025","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40834996","citation_count":0,"is_preprint":false},{"pmid":"41293011","id":"PMC_41293011","title":"NEUROG3 Is Sufficient to Drive Neuroendocrine Differentiation in Prostate Cancer Cells.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41293011","citation_count":0,"is_preprint":false},{"pmid":"42123429","id":"PMC_42123429","title":"Ngn3 Regulates Differentiation Competence of Retinal Progenitor Cells Through Transcriptional and Epigenetic Modification.","date":"2026","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/42123429","citation_count":0,"is_preprint":false},{"pmid":"41928786","id":"PMC_41928786","title":"Epigenetic control of PDX1 and NGN3 by a computationally designed PRC2 inhibitor enforces pancreatic endocrine differentiation from pluripotent stem cells.","date":"2026","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/41928786","citation_count":0,"is_preprint":false},{"pmid":"15774173","id":"PMC_15774173","title":"[In vitro evidence for pancreatic lineage: Ngn3 positive cells are endocrine progenitors derived from cultured islets].","date":"2005","source":"Zhonghua wai ke za zhi [Chinese journal of surgery]","url":"https://pubmed.ncbi.nlm.nih.gov/15774173","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.16.680258","title":"Novel lentiviral constructs for the specification of rare and ectopic cell types in human colonoids","date":"2025-10-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.16.680258","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.06.18.25329871","title":"Tracing Early Molecular Drivers of Gastrinoma in MEN1: A Systematic Review for Precision Surveillance and Improved Patient Outcomes","date":"2025-06-20","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.18.25329871","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.30.610555","title":"<i>Limosilactobacillus reuteri</i>  promotes the expression and secretion of enteroendocrine- and enterocyte-derived hormones","date":"2024-08-31","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.30.610555","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47110,"output_tokens":8400,"usd":0.133665,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18241,"output_tokens":5508,"usd":0.114452,"stage2_stop_reason":"end_turn"},"total_usd":0.248117,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"HNF-6 (ONECUT1) directly binds to and activates the ngn3 gene promoter, establishing HNF-6 as the first identified positive transcriptional regulator of Neurog3 in the developing pancreas. Loss of HNF-6 in mice nearly abolishes Ngn3 expression and impairs endocrine cell differentiation.\",\n      \"method\": \"Promoter binding assay, mouse knockout (hnf6-/-), expression analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct promoter binding demonstrated, corroborated by in vivo knockout phenotype showing loss of Ngn3 expression; replicated conceptually by later studies on upstream regulators\",\n      \"pmids\": [\"10825208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Ngn3 directly binds chromatin at the IA1 promoter and activates IA1 transcription in adult pancreatic duct cells. IA1 expression is absent in Ngn3-null embryos but is normal in embryos mutant for downstream factors (NeuroD1, Arx, Pax4, Pax6), placing IA1 as a direct, early Ngn3 target gene.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), ectopic Ngn3 expression in adult duct cells, genetic epistasis in multiple transcription factor mutant embryos\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP demonstrated direct chromatin binding; genetic epistasis in multiple mutant backgrounds firmly positions IA1 as direct Ngn3 target\",\n      \"pmids\": [\"16511571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Ngn3 protein exhibits biphasic expression during mouse pancreatic development (E8.5–E11.0 first wave; E12.0 onward second wave), and Ngn3 transcripts are markedly more widespread than NGN3 protein in the pancreatic epithelium, indicating substantial post-transcriptional regulation of Ngn3.\",\n      \"method\": \"mRNA in situ hybridization, immunofluorescence protein detection throughout embryonic development\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct protein vs. mRNA comparison by two independent detection methods in one study; single lab\",\n      \"pmids\": [\"18924236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Myt1b and Ngn3 form a feed-forward expression loop: Myt1b potentiates Ngn3 transcription in pancreatic progenitors, and Ngn3 protein production in turn induces Myt1 expression. Pancreatic Myt1 expression largely depends on Ngn3 activity.\",\n      \"method\": \"Gain-of-function overexpression, analysis of Ngn3-null mutant pancreata, expression profiling\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional epistasis using Ngn3-null mice plus gain-of-function; single lab, two complementary approaches\",\n      \"pmids\": [\"18394599\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Neurog3 mRNA and protein are present not only in endocrine progenitors but also in hormone-expressing islet cells (embryonic and adult). Conditional inactivation of Neurog3 in insulin-expressing beta cells or Pdx1-expressing islet cells impairs endocrine function and reduces expression of Neurog3 target genes required for islet maturation, demonstrating that sustained Neurog3 expression is required for islet maturation and function beyond its progenitor role.\",\n      \"method\": \"Neurog3 knock-in reporter mice (3 independent lines), mRNA/protein assays, conditional knockout (Cre-lox)\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — three independent reporter lines plus conditional KO with defined functional phenotype; multiple orthogonal methods in one study\",\n      \"pmids\": [\"19487660\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Neurog3 gene dosage directly controls endocrine commitment: high levels of Neurog3 are required for endocrine fate specification from multipotent pancreatic progenitors, while reduced Neurog3 expression causes progenitors to adopt ductal or acinar fates instead.\",\n      \"method\": \"Neurog3 heterozygosity and hypomorphic allele (gene-dosage manipulation), lineage analysis, cell fate tracking\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic gene dosage series (null, hypomorph, heterozygous, wild-type) with quantitative cell-fate readout; multiple alleles constitute independent replication within one study\",\n      \"pmids\": [\"20025861\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Rfx6 is transcriptionally downstream of Ngn3: Rfx6 expression is lost in Ngn3-null mice and is maintained in embryos lacking NeuroD, Pax4, and Arx, placing Rfx6 directly below Ngn3 in the endocrine differentiation hierarchy. Loss-of-function studies in zebrafish show Rfx6 is required for differentiation of glucagon-, ghrelin-, and somatostatin-expressing cells.\",\n      \"method\": \"Gene expression profiling of isolated Ngn3+ progenitors, analysis in Ngn3-null and other transcription factor mutant embryos (epistasis), zebrafish loss-of-function\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — epistasis in multiple mutant backgrounds definitively places Rfx6 downstream of Ngn3; zebrafish loss-of-function provides functional validation\",\n      \"pmids\": [\"20040487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NEUROG3 is required for endocrine pancreas and enteroendocrine cell development in humans: biallelic loss-of-function mutations (including a nonsense mutation E28X and a missense L135P) abolish NEUROG3 binding to the NEUROD1 promoter E-box in vitro and eliminate its ability to induce ectopic endocrine cell formation and delamination in chicken endoderm electroporation assays. Patients with null mutations lack enteroendocrine cells entirely and develop neonatal diabetes.\",\n      \"method\": \"In vitro E-box binding assay (NEUROD1 promoter), in ovo chicken endoderm electroporation, intestinal biopsy immunostaining\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vitro biochemical assay plus in vivo functional assay; both mutant isoforms tested; human patient phenotype corroborates\",\n      \"pmids\": [\"21378176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Ngn3-expressing endocrine progenitor cells provide a cell-extrinsic feedback signal to adjacent multipotent ductal progenitor cells that activates Notch signaling, limiting further endocrine differentiation and promoting proper duct morphogenesis. Ngn3-/- mice have reduced branching and enlarged duct-like structures, and forced surplus endocrine progenitors reduce duct caliber.\",\n      \"method\": \"Ngn3 knockout mouse analysis, forced endocrine progenitor generation, Notch signaling measurement\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function and gain-of-function with defined morphogenetic readout; single lab\",\n      \"pmids\": [\"21888903\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ATOH1/MATH1 is essential for intestinal tuft cell differentiation whereas Neurog3 is dispensable for tuft cell fate, distinguishing tuft cells from enteroendocrine cells (which require Neurog3).\",\n      \"method\": \"Conditional knockout mouse models (Neurog3-null, ATOH1-null), immunostaining for tuft cell markers\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function distinguishes Neurog3-dependent versus independent lineages; clean negative result for tuft cells is mechanistically informative\",\n      \"pmids\": [\"21383077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Mutagenesis and chromatin immunoprecipitation demonstrate that Ngn3 directly targets the proximal E-boxes of the Insm2 promoter. Endogenous Insm2 expression is activated in Ngn3/NeuroD1-transduced pancreatic epithelial duct cells, establishing Insm2 as a direct transcriptional target of Ngn3.\",\n      \"method\": \"Promoter mutagenesis, chromatin immunoprecipitation (ChIP), ectopic Ngn3/NeuroD1 expression in pancreatic duct cells\",\n      \"journal\": \"Endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — ChIP and promoter mutagenesis directly demonstrate binding and transactivation; single lab but two complementary methods\",\n      \"pmids\": [\"21343251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CCAR1 physically interacts with Ngn3 (verified by pull-down and co-immunoprecipitation) and is required as a coactivator for Ngn3 to activate NeuroD promoter-driven reporter gene expression. Knockdown of endogenous CCAR1 in PANC-1 cells inhibits Ngn3-initiated transdifferentiation toward endocrine fate.\",\n      \"method\": \"Pulldown assay, co-immunoprecipitation, luciferase reporter assay, siRNA knockdown\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal protein interaction assays plus functional reporter and knockdown; single lab\",\n      \"pmids\": [\"22266316\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"STAT3 directly binds the distal Neurog3 promoter/enhancer region in THY1+ spermatogonia and regulates Neurog3 transcription. GDNF (a self-renewal factor for spermatogonial stem cells) suppresses STAT3 activation and consequently represses Neurog3 expression. Transient inhibition of Neurog3 in spermatogonia impairs SSC differentiation in vitro and in vivo transplantation assays.\",\n      \"method\": \"ChIP (STAT3 at Neurog3 promoter), pharmacological JAK/STAT inhibition, RNAi knockdown, transplantation assay\",\n      \"journal\": \"Biology of reproduction\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP demonstrates direct binding; multiple orthogonal methods (ChIP, RNAi, transplantation) in one study\",\n      \"pmids\": [\"22378757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Notch signaling regulates Ngn3 not only at the transcriptional level but also via a post-translational mechanism: Notch>Hes1 pathway activation destabilizes Ngn3 protein. Inhibition of Notch signaling in mouse pancreas explants leads to Ngn3 protein stabilization. Ngn3 also cell-extrinsically activates the Dll1>Notch>Hes1 lateral inhibition pathway, which feeds back to limit endocrine differentiation.\",\n      \"method\": \"Conditional Ngn3 expression in pancreas, Notch inhibitor treatment of pancreas explants, protein stability assays\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological Notch inhibition with protein stabilization readout; conditional expression model; single lab\",\n      \"pmids\": [\"23370147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Insm1 positively regulates Neurog3: embryos lacking Insm1 contain greater amounts of a non-coding Neurog3 mRNA splice variant and have fewer Neurog3/Insm1 co-expressing progenitor cells, suggesting Insm1 modulates correct Neurog3 mRNA splicing/expression during endocrine progenitor differentiation.\",\n      \"method\": \"Insm1 GFP-Cre reporter knock-in mouse, transcriptomic analysis of Insm1-null endocrine progenitors, expression profiling\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo genetic loss-of-function with transcriptomic readout; single lab\",\n      \"pmids\": [\"25053427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NEUROG3 is required for human endocrine pancreas development: CRISPR/Cas9 biallelic disruption of NEUROG3 in human ESCs blocks endocrine cell formation both in vitro and after engraftment in mice. A 75–90% knockdown of NEUROG3 reduces but does not eliminate endocrine cell formation, and as little as 10% NEUROG3 is sufficient for endocrine cell production.\",\n      \"method\": \"CRISPR/Cas9 gene targeting in hESCs, in vitro differentiation, mouse engraftment, NEUROG3 knockdown titration\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complete genetic knockout plus dose-response knockdown in human cell model, with both in vitro and in vivo readouts\",\n      \"pmids\": [\"25650326\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Hnf1b occupies Ngn3 putative regulatory sequences in vivo, and inactivation of Hnf1b at different embryonic time points results in absence of Ngn3+ endocrine precursors throughout embryogenesis, establishing Hnf1b as a direct upstream regulator required for endocrine progenitor generation.\",\n      \"method\": \"Constitutive and inducible conditional Hnf1b knockout mice, ChIP for Hnf1b at Ngn3 regulatory sequences, endocrine precursor quantification\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP demonstrates direct Hnf1b occupancy at Ngn3 locus; multiple conditional knockout models with consistent phenotype\",\n      \"pmids\": [\"25715395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Inflammatory cytokines activate NGN3 expression in pancreatic ductal cells via STAT3 signaling, driving ductal-to-endocrine cell reprogramming both in vitro (human ductal cell line and mouse ductal cells) and in vivo (intraductal injection, NOD mouse autoimmune diabetes model).\",\n      \"method\": \"Cytokine treatment of human ductal cell line, pancreatic intraductal injection in mice, NOD mouse model, STAT3 inhibition\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo models with pathway inhibition; single lab, multiple models\",\n      \"pmids\": [\"27068459\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A mitotic Neurog3-transcriptionally-active but low-protein (Neurog3TA.LO) cell population in Sox9+ epithelium represents an endocrine-biased progenitor state with prolonged epithelial residency and high mitotic index, functionally separated from the endocrine-committed Neurog3HI state. Limiting Neurog3 expression doubles the mitotic index of this progenitor pool.\",\n      \"method\": \"BAC transgenic Neurog3 reporter, lineage tracing, mitotic index measurement, Neurog3 dose manipulation\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — novel reporter system with quantitative mitotic and lineage readouts; single lab\",\n      \"pmids\": [\"27585590\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"NEUROG3 is phosphorylated on serine 183 within the nucleus, which catalyzes its hyperphosphorylation and proteasomal degradation. This phosphorylation is driven by cyclin-dependent kinases 2 and 4/6 at the G1/S cell-cycle checkpoint. G1-phase lengthening in pancreatic progenitors stabilizes NEUROG3 and is essential for initiating endocrine differentiation.\",\n      \"method\": \"Phospho-specific antibodies, site-directed mutagenesis (S183), CDK inhibitor treatment, mouse and human pancreas development models, cell-cycle manipulation\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — phosphosite identified by mutagenesis, CDK writers identified by inhibition, functional consequence (protein stability and differentiation) demonstrated in both mouse and human models\",\n      \"pmids\": [\"28441528\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Nkx2.2 functions downstream of Neurog3: conditional ablation of Nkx2.2 specifically in the Neurog3+ endocrine progenitor lineage (using Neurog3-Cre) recapitulates the full Nkx2.2-null β-cell differentiation defect, demonstrating that Nkx2.2's essential activity for β-cell specification occurs within the Neurog3+ progenitor population.\",\n      \"method\": \"Conditional knockout using Neurog3-Cre, comparison of Nkx2.2 whole-body null vs. lineage-specific null phenotypes\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis using lineage-specific conditional KO; phenotypic comparison between whole-body and Neurog3-lineage-specific nulls definitively places Nkx2.2 downstream of Neurog3\",\n      \"pmids\": [\"28071588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The ROCK-nmMyoII pathway coordinates epithelial morphogenesis with Neurog3 expression: nmMyoII is necessary for apical narrowing, basalward cell displacement, and Neurog3 transcriptional upregulation, but all three are limited by ROCK activity. Neurog3 protein is required for cell-rear detachment and complete endocrine-cell birth from the epithelial plexus.\",\n      \"method\": \"Pharmacological ROCK/nmMyoII inhibition, Neurog3-null analysis, live imaging of epithelial egression\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological manipulation and genetic null with morphogenetic and transcriptional readouts; single lab\",\n      \"pmids\": [\"30126902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Hes1 loss causes ectopic pancreas through Neurog3-dependent mechanisms: genetic inactivation of Neurog3 in a Hes1-null background normalizes early pancreas morphogenesis and suppresses the ectopic pancreas phenotype, demonstrating that aberrant upregulation of Neurog3-driven endocrine differentiation drives the dysgenesis.\",\n      \"method\": \"Double mutant epistasis (Hes1-/-; Neurog3-/-), lineage tracing, live imaging, RNA-seq of sorted cells\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — double-mutant epistasis plus RNA-seq; rescue of morphogenetic phenotype by Neurog3 deletion firmly establishes pathway order\",\n      \"pmids\": [\"30093553\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NGN3 loss-of-function in pigs (CRISPR/Cas9 biallelic knockout) eliminates expression of downstream target genes NEUROD1 and PAX4, and abolishes insulin, glucagon, somatostatin, and pancreatic polypeptide-Y, confirming NGN3's conserved essential role in porcine endocrine pancreas development.\",\n      \"method\": \"CRISPR/Cas9 gene ablation in pigs, immunostaining and gene expression analysis of NGN3 knockout fetuses and neonates\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complete in vivo knockout in large animal model with comprehensive hormone and target gene readout; multiple downstream targets confirmed absent\",\n      \"pmids\": [\"29483633\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Neurog3-independent DNA methylation at the Arx enhancer in pancreatic progenitors pre-specifies endocrine cell type fate: progenitors with higher Dnmt1 expression and Arx enhancer hypermethylation are biased toward β-cell fate, while those with lower methylation favor α-cell fate. This methylation state is established before Neurog3 activation and is not determined by Neurog3 itself.\",\n      \"method\": \"Single-cell RNA-seq, trajectory analysis, combinatorial lineage tracing (Myt1+Neurog3+ vs Myt1-Neurog3+), DNMT inhibition, Dnmt1 overexpression, targeted Arx enhancer methylation analysis\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal approaches (scRNA-seq, lineage tracing, epigenetic perturbation, locus-specific methylation) in single study; mechanistically distinguishes Neurog3-independent from Neurog3-dependent fate programs\",\n      \"pmids\": [\"30620902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Genome-wide NEUROG3 occupancy mapping (CUT&RUN) in human iPSC-derived endocrine progenitors identified 863 binding sites assigned to 1263 genes, with a defined consensus NEUROG3 binding motif. NEUROG3 directly occupies promoters and enhancers of transcription factors essential for islet development (NEUROD1, PAX4, NKX2-2, SOX4, RFX3, NEUROG3 itself) and genes critical for beta-cell function (GCK, ABCC8/KCNJ11, CACNA1A, SLC30A8, PCSK1). 22% of genes downregulated in NEUROG3-/- progenitors are directly bound by NEUROG3.\",\n      \"method\": \"CUT&RUN chromatin occupancy mapping, hiPSC differentiation with HA-tagged NEUROG3, de novo motif analysis, integration with NEUROG3-/- transcriptomics\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genome-wide direct binding mapped by CUT&RUN with HA-tagged endogenous NEUROG3; integrated with KO transcriptomics to distinguish direct from indirect targets; multiple orthogonal approaches\",\n      \"pmids\": [\"34352411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"USP7 (a deubiquitylating enzyme) physically interacts with, deubiquitinates, and stabilizes NGN3 protein. Conditional knockout of Usp7 in mouse embryonic pancreas dramatically reduces islet formation and causes adult hyperglycemia by impairing NGN3-mediated endocrine specification. Pharmacological inhibition of USP7 during human iPSC-derived beta-cell differentiation decreases NGN3+ progenitor numbers and impairs beta-cell differentiation.\",\n      \"method\": \"Binding partner screen, co-immunoprecipitation, deubiquitination assay, conditional Usp7 knockout in pancreas (Cre-lox), human iPSC differentiation with USP7 inhibitor\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — biochemical reconstitution of deubiquitination, reciprocal co-IP, in vivo conditional KO with islet phenotype, and human iPSC model; multiple orthogonal methods across mouse and human systems\",\n      \"pmids\": [\"37117185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NGN3 protein oscillates with ~13-hour periodicity in human iPSC-derived endocrine progenitors and is extinguished upon differentiation. Stabilizing NGN3 protein (increasing protein stability) converts oscillations to a single broad peak and causes precocious endocrine differentiation and earlier expression of NGN3 target genes. Mathematical modeling and experimental validation indicate NGN3 oscillations are decoded via fold-change detection (FCD) through an incoherent feedforward loop (IFFL) motif.\",\n      \"method\": \"Knockin endogenous NGN3 reporter in hiPSCs, live imaging, protein stability manipulation, single-cell dynamics analysis, mathematical modeling\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — endogenous reporter quantifies protein dynamics; protein stabilization experiment demonstrates causal role of oscillation pattern; mathematical model validated experimentally; multiple orthogonal approaches\",\n      \"pmids\": [\"40570854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NGN3 functions as a pioneer transcription factor that remodels chromatin accessibility during pancreatic endocrine differentiation. NGN3's pioneering function exhibits dose tolerance (low doses are sufficient). In the absence of NGN3, NEUROD1 can assume a pioneering role. Sequential expression of NeuroD1 before Ngn3 predominantly drives α-cell generation, explaining inefficient β-cell induction in certain in vitro contexts.\",\n      \"method\": \"Genetically engineered mouse model, NGN3 ChIP/binding site mapping, ATAC-seq (chromatin accessibility), manipulation of TF expression order\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — genome-wide chromatin accessibility (ATAC-seq) plus binding site mapping plus sequential expression manipulation; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"40138419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Ectopic Neurog3 in chicken endoderm requires full transcriptional activity for migration of electroporated cells: fusing Neurog3 to VP16 or co-electroporation with Ep300 (increased transcriptional activity) causes cells to migrate rather than differentiate, while reducing transcriptional activity (deletion of activation domain, engrailed repressor fusion, Hdac1 co-expression) greatly increases glucagon-expressing cell production.\",\n      \"method\": \"In ovo chicken endoderm electroporation, Neurog3 activation-domain deletion mutants, Neurog3-VP16 and Neurog3-EnR fusions, co-electroporation with Ep300 or Hdac1\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — structure-function analysis with multiple activation domain mutants in a defined in vivo assay; single lab\",\n      \"pmids\": [\"20549731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"E2f1 binds and activates the Ngn3 promoter in a Cdk4-dependent manner in the embryonic pancreas. Expression of activated Cdk4(R24C) kinase increases the number and proliferation of Ngn3+ endocrine precursors, leading to β-cell expansion.\",\n      \"method\": \"ChIP (E2f1 at Ngn3 promoter), Cdk4 knockout and Cdk4(R24C) gain-of-function mouse models, Ngn3+ cell quantification\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP demonstrates direct E2f1 binding at Ngn3 promoter; both loss-of-function and gain-of-function genetic models with quantitative endocrine precursor readout\",\n      \"pmids\": [\"21490060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"GDF11 (acting through SMAD2) negatively regulates the number of NGN3+ islet progenitor cells in the mouse pancreas. Gdf11-null mice have increased NGN3+ cell numbers but reduced beta-cell numbers, indicating GDF11/SMAD2 signaling controls both progenitor pool size and beta-cell maturation downstream or in parallel with Notch pathway regulation of NGN3+ cells.\",\n      \"method\": \"Gdf11-null and Smad2-null mouse analysis, NGN3+ cell quantification, beta-cell counting\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent genetic loss-of-function models (Gdf11-/-, Smad2-/-) with consistent NGN3+ progenitor expansion phenotype\",\n      \"pmids\": [\"15548585\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NEUROG3 is a bHLH transcription factor that acts as the master regulator of pancreatic and intestinal endocrine lineage specification: it is transcriptionally activated by upstream regulators (HNF-6/ONECUT1, HNF1B, E2F1/CDK4, STAT3) and its protein levels are tightly controlled post-translationally by CDK2/4/6-driven phosphorylation on S183 (promoting proteasomal degradation), Notch/Hes1-mediated destabilization, and USP7-mediated deubiquitination and stabilization; in human progenitors NGN3 protein oscillates (~13h periodicity) with oscillatory dynamics decoded by fold-change detection to control differentiation timing; as a pioneer transcription factor it remodels chromatin and directly occupies hundreds of target gene loci (NEUROD1, PAX4, NKX2-2, GCK, ABCC8, RFX3, and many others) to initiate the endocrine gene program, while cell-extrinsically activating Dll1>Notch>Hes1 lateral inhibition to limit the number of cells undergoing endocrine commitment; the threshold level of NEUROG3 determines cell fate allocation (high levels drive endocrine commitment; low levels allow ductal/acinar fates), and sustained NEUROG3 expression in hormone-expressing islet cells continues to be required for islet maturation and function beyond the initial progenitor specification event.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NEUROG3 (NGN3) is a basic helix-loop-helix transcription factor that acts as the master initiator of endocrine lineage specification in the pancreas and intestine [#5, #15]. Its expression is set by a hierarchy of direct upstream activators that bind its promoter/enhancer — HNF-6/ONECUT1 [#0], HNF1B [#16], E2F1 acting in a CDK4-dependent manner [#30], and STAT3 in response to inflammatory cytokines and in non-pancreatic contexts [#12, #17] — while GDF11/SMAD2 signaling restrains the size of the NGN3+ progenitor pool [#31]. Functioning as a pioneer transcription factor, NGN3 remodels chromatin accessibility and directly occupies promoters and enhancers of hundreds of target genes, including the endocrine transcription factors NEUROD1, PAX4, NKX2-2, RFX6/RFX3 and INSM2, and beta-cell functional genes such as GCK and ABCC8, thereby launching the islet gene program [#1, #6, #10, #25, #28]. Cell-fate output is dose-dependent: high NGN3 drives endocrine commitment whereas low levels permit ductal/acinar fates [#5, #15], and its pioneering activity is dose-tolerant such that NEUROD1 can substitute when NGN3 is absent, with the order of factor expression biasing alpha- versus beta-cell production [#28]. NGN3 protein abundance is tightly controlled post-translationally: CDK2/4/6 phosphorylate serine 183 to trigger proteasomal degradation, coupling endocrine differentiation to G1-phase lengthening [#19]; Notch/Hes1 signaling destabilizes the protein [#13]; and USP7 deubiquitinates and stabilizes it [#26]. In human progenitors NGN3 protein oscillates with ~13-hour periodicity, and these dynamics are decoded by fold-change detection through an incoherent feedforward loop to time differentiation [#27]. NGN3 in turn activates Dll1>Notch>Hes1 lateral inhibition to limit the number of cells entering the endocrine program and shape duct morphogenesis [#8, #13, #22], and it is required for epithelial egression of nascent endocrine cells [#21]. Beyond initial specification, sustained NGN3 in hormone-expressing islet cells is needed for islet maturation and function [#4]. Biallelic loss-of-function mutations in human NEUROG3 cause neonatal diabetes with absent enteroendocrine cells [#7].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing how Neurog3 is switched on, HNF-6 was identified as the first direct upstream activator, anchoring the gene in a transcriptional hierarchy rather than acting in isolation.\",\n      \"evidence\": \"Promoter binding assay and hnf6-/- mouse with loss of Ngn3 expression\",\n      \"pmids\": [\"10825208\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the full set of cofactors at the Ngn3 promoter\", \"Did not address post-transcriptional control of Ngn3\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"GDF11/SMAD2 signaling was shown to set the size of the NGN3+ progenitor pool, identifying an extrinsic brake on endocrine progenitor number.\",\n      \"evidence\": \"Gdf11-null and Smad2-null mice with progenitor quantification\",\n      \"pmids\": [\"15548585\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic link to Notch regulation only inferred\", \"Did not define whether effect is on NGN3 transcription or progenitor proliferation\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Direct chromatin binding at IA1, validated by epistasis against downstream factors, moved NGN3 from a presumed regulator to a demonstrated direct activator of early endocrine target genes.\",\n      \"evidence\": \"ChIP and ectopic expression in duct cells with genetic epistasis across multiple TF mutants\",\n      \"pmids\": [\"16511571\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single target locus, not genome-wide\", \"Did not define cofactor requirements for activation\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The mismatch between widespread Ngn3 mRNA and restricted protein revealed that post-transcriptional control, not just transcription, governs where NGN3 acts.\",\n      \"evidence\": \"Parallel mRNA in situ and protein immunofluorescence across embryogenesis; plus Myt1b/Ngn3 feed-forward loop by epistasis\",\n      \"pmids\": [\"18924236\", \"18394599\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism of protein restriction not identified in these studies\", \"Single-lab observations\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Gene-dosage and conditional studies established that NGN3 level is a fate determinant and that its requirement extends beyond progenitor specification into islet maturation.\",\n      \"evidence\": \"Allelic dosage series with lineage tracking; conditional KO in hormone+ cells with reporter lines\",\n      \"pmids\": [\"20025861\", \"19487660\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the molecular threshold sensor\", \"Mechanism of sustained maturation role left open\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Defining the target hierarchy and the role of transcriptional activity, Rfx6 was placed directly downstream and NGN3's activation-domain strength was shown to switch cells between migration and differentiation.\",\n      \"evidence\": \"Epistasis in mutant embryos plus zebrafish loss-of-function; activation-domain mutant and VP16/EnR fusions in chick electroporation\",\n      \"pmids\": [\"20040487\", \"20549731\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Coactivators bridging NGN3 to target promoters not yet identified\", \"Migration-versus-differentiation switch mechanism unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Multiple studies cemented NGN3's direct target repertoire (Insm2), its requirement in humans, and its non-cell-autonomous role in feeding back via Notch to shape duct morphogenesis and limit endocrine commitment.\",\n      \"evidence\": \"ChIP and promoter mutagenesis (Insm2); human patient mutations with E-box binding and chick electroporation assays; Ngn3-null/gain-of-function morphogenesis; E2f1/Cdk4-dependent promoter activation\",\n      \"pmids\": [\"21343251\", \"21378176\", \"21888903\", \"21490060\", \"21383077\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct ligand/receptor mediating the feedback signal not fully resolved\", \"Genome-wide binding map still lacking at this point\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"A coactivator (CCAR1) and a context-specific upstream activator (STAT3 in spermatogonia) extended the regulatory and functional network around NGN3 beyond the pancreas.\",\n      \"evidence\": \"Reciprocal Co-IP/pull-down and reporter/knockdown for CCAR1; ChIP and RNAi/transplantation for STAT3\",\n      \"pmids\": [\"22266316\", \"22378757\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"CCAR1 interaction from single lab without structural detail\", \"Role of NGN3 outside endocrine tissues incompletely defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Notch was shown to control NGN3 post-translationally by destabilizing the protein, distinguishing transcriptional from protein-level regulation in the lateral-inhibition circuit.\",\n      \"evidence\": \"Notch inhibition of pancreas explants with protein stability readout; conditional Ngn3 expression\",\n      \"pmids\": [\"23370147\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not identify the degradation machinery\", \"Single-lab pharmacological approach\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Insm1 was found to support correct Neurog3 mRNA splicing/expression, adding an RNA-level layer to NGN3 control during progenitor differentiation.\",\n      \"evidence\": \"Insm1-null reporter mouse with transcriptomic analysis of progenitors\",\n      \"pmids\": [\"25053427\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct splicing mechanism not demonstrated\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Human genetic and stem-cell models established the conserved, dose-dependent requirement of NEUROG3 for human endocrine development, and Hnf1b was confirmed as a direct upstream regulator.\",\n      \"evidence\": \"CRISPR knockout and knockdown titration in hESCs with in vitro/engraftment readouts; conditional Hnf1b KO with ChIP at Ngn3 locus\",\n      \"pmids\": [\"25650326\", \"25715395\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why as little as 10% NGN3 suffices not mechanistically explained\", \"Did not map genome-wide NGN3 targets in human cells\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Inflammatory STAT3 signaling was shown to reactivate NGN3 and drive ductal-to-endocrine reprogramming, and a transcriptionally-active but low-protein progenitor state was defined, linking NGN3 level to proliferative versus committed states.\",\n      \"evidence\": \"Cytokine/STAT3 manipulation in ductal cells and NOD mice; BAC reporter with lineage tracing and mitotic index\",\n      \"pmids\": [\"27068459\", \"27585590\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stability of reprogrammed endocrine cells not established\", \"Single-lab reporter system\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"The S183 phosphodegron and its CDK2/4/6 writers were identified, mechanistically coupling NGN3 protein stability to cell-cycle state and explaining how G1 lengthening initiates differentiation; Nkx2.2 was placed downstream within the NGN3 lineage.\",\n      \"evidence\": \"Phospho-specific antibodies, S183 mutagenesis, CDK inhibition in mouse/human models; Neurog3-Cre lineage-specific Nkx2.2 KO\",\n      \"pmids\": [\"28441528\", \"28071588\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"E3 ligase mediating S183-dependent degradation not identified here\", \"Did not address deubiquitination counterbalance\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Studies connected NGN3 to epithelial morphogenesis and established it as the effector driving Hes1-loss dysgenesis, showing NGN3 both responds to and remodels tissue architecture.\",\n      \"evidence\": \"ROCK/nmMyoII inhibition with live imaging and Ngn3-null; Hes1-/-;Neurog3-/- double-mutant epistasis with RNA-seq\",\n      \"pmids\": [\"30126902\", \"30093553\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular link between NGN3 and the cell-detachment machinery undefined\", \"Morphogenetic role single-lab for nmMyoII arm\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"An NGN3-independent epigenetic prepattern (Arx enhancer methylation) was shown to bias alpha- versus beta-cell fate before NGN3 acts, delineating the boundary of NGN3's instructive role.\",\n      \"evidence\": \"scRNA-seq, combinatorial lineage tracing, DNMT perturbation, locus-specific methylation analysis\",\n      \"pmids\": [\"30620902\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How NGN3 integrates with the pre-set methylation state not resolved\", \"Upstream determinant of differential Dnmt1 levels unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Genome-wide occupancy mapping in human progenitors converted the piecemeal target list into a defined direct regulatory network and consensus motif, distinguishing direct from indirect targets.\",\n      \"evidence\": \"CUT&RUN with HA-tagged NEUROG3 in hiPSC progenitors integrated with NEUROG3-/- transcriptomics\",\n      \"pmids\": [\"34352411\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional weight of individual binding sites untested\", \"Did not directly demonstrate chromatin remodeling at bound sites\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"USP7 was identified as the deubiquitinase that stabilizes NGN3, providing the counterweight to phosphodegron-driven turnover and a tractable node for controlling endocrine specification.\",\n      \"evidence\": \"Co-IP, deubiquitination assay, conditional Usp7 pancreas KO, and USP7 inhibition in human iPSC beta-cell differentiation\",\n      \"pmids\": [\"37117185\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The cognate E3 ubiquitin ligase opposing USP7 not identified\", \"Coupling between USP7 and S183 phosphorylation not resolved\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"NGN3 protein dynamics and chromatin function were defined: ~13h oscillations decoded by fold-change detection time differentiation, and NGN3 acts as a dose-tolerant pioneer factor whose expression order with NeuroD1 dictates alpha/beta-cell output.\",\n      \"evidence\": \"Endogenous knockin reporter with live imaging, protein stabilization, and mathematical modeling; ATAC-seq, binding mapping and sequential TF expression in mouse model\",\n      \"pmids\": [\"40570854\", \"40138419\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular machinery generating the oscillation not fully defined\", \"How fold-change is sensed at the chromatin level unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The full degradation machinery (E3 ligase) acting on phospho-S183 NGN3, and how oscillatory protein dynamics are mechanistically read out at target chromatin to set the differentiation threshold, remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No E3 ligase opposing USP7 identified\", \"Chromatin-level decoder of fold-change detection unknown\", \"Quantitative link between protein threshold and individual target activation undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 7, 25, 28]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [1, 7, 10, 25, 28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [1, 25, 28]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 15, 23]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [28]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CCAR1\", \"USP7\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":9,"faith_total":9,"faith_pct":100.0}}